Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPantheon International Regulatory News (PIN)

Share Price Information for Pantheon International (PIN)

Share Price is delayed by 15 minutes
Get Live Data
400.00    -2.00 (-0.50%)
Bid:
400.00
Ask:
401.00
Spread: 1.00 (0.25%)
Market Cap: £1.63b
PIN Live PriceLast checked at - London Stock Exchange

Intraday Pantheon International Share Chart

Monthly Performance Update

20 Oct 2017 07:00

RNS Number : 1339U
Pantheon International PLC
20 October 2017
 

20 October 2017

 

Pantheon International Plc

Performance Update at 30 September 2017

 

Month to 30 September 2017

 

As announced on 28 September 2017, Pantheon International Plc ("PIP") is putting forward proposals to consolidate its ordinary and redeemable share capital into a single class of ordinary shares. The proposals will include the issue of a £200m asset linked note to the largest holder of the Company's redeemable shares. An Extraordinary General Meeting and Class Meetings have been convened on 30 October 2017 for the purpose of implementing the proposals. For further details, please see www.piplc.com/investor-relations/proposed-share-consolidation 

 

PIP announced an unaudited net asset value ("NAV") per share at 30 September 2017 of 2,208.7p, a decrease of 94.0p (-4.1%) from the NAV per share as at 31 August 2017. Investment income (3.3p, 0.1%) was offset by valuation losses (-2.4p, 0.0%), foreign exchange movements (-89.1p, -3.9%) and expenses and taxes* (-5.8p, -0.3%).

PIP's valuation policy for private equity funds is based on the latest valuations reported by the managers of the funds in which PIP has holdings. In the case of PIP's valuation at 30 September 2017, 100% of reported valuations are dated 30 June 2017 or later.

At 30 September 2017, PIP's private equity assets stood at £1,248m, whilst cash balances were £157m. Undrawn commitments to investments stood at £457m at 30 September 2017, calculated using exchange rates at that date. PIP's multi-currency revolving credit facilities comprise a US$138.8m facility and a €66.6m facility, which remained completely undrawn as at 30 September 2017.

 

PIP's portfolio generated net cash of £26.9m during the month, with distributions of £37.4m relative to £10.5m of calls from existing commitments to private equity funds.

 

PIP completed five new investments during the month, amounting to £32.8m in new commitments. This included a £14.8m secondary investment in a European mid-market buyout fund principally focused on France and Germany that was 97% funded at completion. PIP also made a primary commitment of £8.6m to Water Street Healthcare Partners IV, a North American small buyout fund. PIP committed £9.4m to three co-investments including a £3.6m investment alongside Altamont Capital Partners in Sequel Youth and Family Services, a US-based operator of treatment centres for people with behavioural, emotional or physical challenges, and a £3.2m investment alongside Sageview Capital in CallRail, a B2B software company that provides phone analytics for data-driven businesses.

 

 * Expenses during the month to 30 September 2017 include transaction costs associated with the share consolidation proposals. Taxes relate to withholding taxes on investment distributions.

 

 

Monthly Report

The September monthly newsletter can be accessed on PIP's website at www.piplc.com in the Investor Relations section under the heading "Newsletters", or by following this link: http://www.piplc.com/investor-relations/newsletters.

 

Ends

 

 

 

 

 

NOTES

PIP

PIP is a London quoted investment trust, managed by Pantheon Ventures (UK) LLP ("Pantheon"), a leading global private equity fund investor, investing in both primary funds and secondary transactions, and from time to time capitalising further on its fund investment activities by acquiring direct holdings in unquoted companies, usually either where a vendor is seeking to sell a combined portfolio of fund interests and direct holdings or where there is a private equity manager, well known to Pantheon, investing on substantially the same terms. With investments in private equity funds, covering multiple private equity strategies ranging from investments in late stage buyouts to early stage venture, PIP enables individuals as well as institutions to gain access to a substantial portfolio of unquoted companies in the USA, the UK, Continental Europe and Asia, within funds managed by experienced private equity managers.

 

Pantheon

Pantheon is a leading global private equity fund investor that invests on behalf of over 400 institutional investors. Established over 35 years ago, Pantheon has developed a strong reputation and track record in primary, secondary and co-investments and across all stages and geographies. Pantheon has £29.2 billion in AUM** (as at 31 March 2017), 227 employees, including 71 investment professionals, located across offices in London, San Francisco, New York, Hong Kong, Seoul and Bogotá.

 

** This figure includes assets subject to discretionary or non-discretionary management, advice or those limited to a reporting function.

 

 

 

For more information please visit PIP's website at www.piplc.com or contact:

 

Andrew Lebus or Vicki Bradley

Pantheon

020 3356 1800

 

Neither the contents of PIP's website nor the contents of any website accessible from hyperlinks on PIP's website (or any other website) is incorporated into, or forms part of this announcement.

 

LEI 2138001B3CE5S5PEE928

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCFFEFMUFWSEES
Date   Source Headline
24th Apr 20187:00 amRNSMonthly Performance Update
5th Mar 20181:42 pmRNSDirector/PDMR Shareholding
5th Mar 20181:42 pmRNSDirector/PDMR Shareholding
2nd Mar 20184:43 pmRNSDirector Declaration
1st Mar 201811:54 amRNSDirector Declaration
27th Feb 20187:00 amRNSHalf-year Report
23rd Feb 20187:00 amRNSMonthly Performance Update
23rd Jan 20187:00 amRNSMonthly Performance Update
18th Jan 20189:15 amRNSDirector Declaration
12th Jan 20187:00 amRNSMonthly Performance Update
2nd Jan 20184:33 pmRNSTotal Voting Rights
7th Dec 20175:33 pmRNSTotal Voting Rights
7th Dec 20175:33 pmRNSTransaction in Own Shares
6th Dec 20175:52 pmRNSTotal Voting Rights
6th Dec 20175:49 pmRNSTransaction in Own Shares
4th Dec 20173:55 pmRNSDirector/PDMR Shareholding
1st Dec 201712:17 pmRNSTotal Voting Rights
24th Nov 20174:45 pmRNSTotal Voting Rights
24th Nov 20174:44 pmRNSTransaction in Own Shares
24th Nov 20177:05 amRNSTotal Voting Rights
24th Nov 20177:00 amRNSTransaction in Own Shares
22nd Nov 20173:45 pmRNSHolding(s) in Company
22nd Nov 20173:05 pmRNSResult of AGM
22nd Nov 20177:00 amRNSMonthly Performance Update
8th Nov 20171:34 pmRNSHolding(s) in Company
7th Nov 201712:08 pmRNSHolding(s) in Company
7th Nov 201711:50 amRNSHolding(s) in Company
7th Nov 201711:50 amRNSHolding(s) in Company
3rd Nov 20172:24 pmRNSHolding(s) in Company
3rd Nov 20171:07 pmRNSHolding(s) in Company
3rd Nov 201711:58 amRNSHolding(s) in Company
2nd Nov 201712:34 pmRNSHolding(s) in Company
1st Nov 20179:00 amRNSCompletion of Consolidation and TVR
30th Oct 20172:25 pmRNSResult of EGM and Class Meetings
20th Oct 20177:00 amRNSMonthly Performance Update
6th Oct 201712:42 pmRNSPublication of Circular and Shareholder Meetings
3rd Oct 201710:43 amRNSDirector/PDMR Shareholding
28th Sep 20175:29 pmRNSDirector/PDMR Shareholding
28th Sep 20174:14 pmRNSDirector/PDMR Shareholding
28th Sep 20177:00 amRNSProposed Share Capital Consolidation and ALN Issue
25th Sep 20177:00 amRNSMonthly Performance Update
23rd Aug 20177:00 amRNSMonthly Performance Update
8th Aug 20177:00 amRNSAnnual Report for the 11 months ended 31 May 2017
31st Jul 20177:00 amRNSMonthly Performance Update
12th Jul 20177:00 amRNSMonthly Performance Update
13th Jun 20175:42 pmRNSDirector Declaration
23rd May 20177:00 amRNSMonthly Performance Update
9th May 20172:49 pmRNSHolding(s) in Company
27th Apr 20177:00 amRNSMonthly Performance Update
18th Apr 20175:16 pmRNSChange of Accounting Reference Date

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.